Creating and distributing additional copies is prohibited without the permission of the publisher. Contact subscriptions@latinfinance.com.

Brazil Pharma Prices FO

Jun 22, 2012

Brazil Pharma has priced a BRL553m ($268m) equity follow-on, landing at a 2.6% discount. The retail pharmaceutical company sold 52.8m...

To continue reading please take a free trial, subscribe or login below.


Already have an account?

Subscribe

Subscribe now for unlimited access to all current and archive news, data and market analysis. 

Subscribe

Free trial

Take a free two-week trial now for the latest news, data and market analysis.

Free Trial

LatinFinance Events

Poll

How busy will LatAm global-local currency debt issuance be this year?

Vote    



  1. Commodities dip raises LatAm growth fears
  2. Cemex enters “new phase” – CFO
  3. Institutional wealth – pension funds: The next generation
  4. Debt investor scorecard: Beating the benchmark
  5. Mexico ECM pipeline refills
Follow us


Popular Searches


The most pressing issue is related to guaranteeing this growth of the system, the savings. We have to guarantee that this growth is followed by better asset managers on the side of the Afores.

Carlos Ramírez, Mexico’s pension regulator, Consar


Change font size: Switch to default font size Switch to medium font size Switch to large font size

All material is subject to strictly enforced copyright terms & conditions and cannot be repurposed or reproduced. © 2013 Latin American Financial Publications Inc.

Printing isn't available for this page.